Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-053590

Chief Executive Officer sold 4,400 shares at an average $15.54 ($68,354)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-09-19 Sale −2,200 $15.51 $34,122 435,178 I
Ciechanover Isaac E. Chief Executive Officer 2017-09-20 Sale −2,200 $15.56 $34,232 432,978 I
Open-market sales · 4,400 sh · avg $15.54 · $68,354
Loading xslF345X03/doc4.xml…